Cargando…
Strategy to Prime the Host and Cells to Augment Therapeutic Efficacy of Progenitor Cells for Patients with Myocardial Infarction
Cell therapy in myocardial infarction (MI) is an innovative strategy that is regarded as a rescue therapy to repair the damaged myocardium and to promote neovascularization for the ischemic border zone. Among several stem cell sources for this purpose, autologous progenitors from bone marrow or peri...
Autores principales: | Kang, Jeehoon, Kim, Tae-Won, Hur, Jin, Kim, Hyo-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121226/ https://www.ncbi.nlm.nih.gov/pubmed/27933299 http://dx.doi.org/10.3389/fcvm.2016.00046 |
Ejemplares similares
-
Long-term use of renin-angiotensin-system inhibitors after acute myocardial infarction is not associated with survival benefits: Analysis of data from the Korean acute myocardial infarction registry-national institutes of health registry
por: Park, Chan Soon, et al.
Publicado: (2022) -
SUMOylation as a Therapeutic Target for Myocardial Infarction
por: Zhao, Wei, et al.
Publicado: (2021) -
Pericardial application as a new route for implanting stem‐cell cardiospheres to treat myocardial infarction
por: Zhang, Jianhua, et al.
Publicado: (2018) -
Hypofunction of Circulating Endothelial Progenitor Cells and Aggravated Severity in Elderly Male Patients With Non-ST Segment Elevation Myocardial Infarction: Its Association With Systemic Inflammation
por: Zeng, Lijin, et al.
Publicado: (2021) -
A cohort study of circulating progenitor cells after ST-segment elevation and non-ST segment elevation myocardial infarction in non-diabetic and diabetic patients
por: Baumbach, Andreas, et al.
Publicado: (2022)